Medical

Proteus mirabilis

Also found in: Dictionary, Encyclopedia, Wikipedia.

Pro·te·us mi·ra·b'i·lis

a bacterial species found in putrid meat, infusions, and abscesses; a cause of urinary tract infections associated with formation of renal and bladder calculi.
Farlex Partner Medical Dictionary © Farlex 2012

Proteus mirabilis

Microbiology A gram-negative pathogen linked to UTIs, wound infections Habitat P mirabilis may be found in water,
soil, feces
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.

Pro·te·us mi·ra·bi·lis

(prō'tē-ŭs mi-rab'i-lis)
A bacterial species widely recognized as a human pathogen commonly recovered from urinary, wound, and bacteremic infections. Recognized in the laboratory by its characteristic "swarming"colony morphology on blood agar.
Medical Dictionary for the Health Professions and Nursing © Farlex 2012
Mentioned in
References in periodicals archive
Phenotypic and molecular characterization of plasmid mediated AmpC [beta]-lactamases among Escherichia coli, Klebsiella spp., and Proteus mirabilis isolated from urinary tract infections in Egyptian hospitals.
Occurrence and detection of Amp C b-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center.
The first was Proteus mirabilis, a Gram-negative facultative anaerobic found in soil and water, while the second pathogen found was Pseudomonas aeruginosa that is a Gram-negative, multidrug-resistant pathogen associated with hospital infections.
Number tested (% Organism of total) ESBL AmpC MBL Citrobacter spp 1 (0.8) 1 (100) 0 0 Escherichia coli 55 (43.7) 22 (40.0) 7 (12.7) 15 (27.3) Klebsiella species 36 (28.6) 30 (83.3) 8 (22.2) 23 (63.9) Proteus mirabilis 6 (4.8) 2 (33.3) 0 1 (16.7) Proteus vulgaris 5 (4.0) 2 (40.0) 0 1 (20.0) Providencia spp 6 (4.8) 4 (66.7) 1 (16.7) 1 (16.7) Alcaligenes spp 5 (4.0) 3 (60.0) 0 0 Pseudomonas aeruginosa 10 (7.9) 1 (10.0) 3 (30.0) 4 (40.0) Pseudomonas fluorescens 1 (0.8) 0 0 0 Acinetobacter species 1 (0.8) 0 0 0 Total 126 65 (51.6) 19 (15.1) 45 (35.7) Number in bracket: percentage.
shimperi were examined at a concentration of 20 [micro]g/mL against four pathogenic bacterial strains: one Gram-positive Staphylococcus aureus and three Gram-negative Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. Antibacterial potential of crude extract and isolated pure compound were assessed in terms of zone of inhibition of bacterial growth.
These isolates have been registered in GenBank under accession numbers (Klebsiella pneumoniae (KY049979), Klebsiella oxytoca (KY031321), Escherichia coli (MG198700), Pseudomonas aeruginosa (MG198702), Citrobacter freundii (MG198698), Acinetobacter baumannii (KY114514), Alcaligenes faecalis (MG198707), Enterobacter cloacae (KY205640), Bacillus horikoshii (MG198701), Staphylococcus aureus (KY176381), Staphylococcus haemolyticus (MG198699), Proteus mirabilis (JF947362), Bacillus cereus (JX218990.1), and Shigella flexneri (KY199565)).
Initially, the stock cultures of Staphylococcus aureus, Salmonella typhi, Providencia alcalifaciens, and Proteus mirabilis were revived by inoculating in broth media and grown at 37[degrees]C for 18 h.
The in vitro antibacterial activity of the prepared ligands and complexes were also evaluated against four bacterial strains e.g., Staphylococcus aureus, Bacillus subtilis, Escherichia Coli and Proteus mirabilis, by the well-diffusion method.
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.